Rice University President David Leebron was joined by dignitaries for the Oct. 30 opening ceremony of the Rice University National Security Research Accelerator laboratories in Dell Butcher Hall. Photo via Rice.edu

A collaboration between Rice University and the United States Army has taken entered into a new phase with the opening of the Rice University National Security Research Accelerator laboratories in Dell Butcher Hall.

RUNSRA, which launched in 2019 with support from Army Futures Command and the Army Research Laboratory, premiered its new home on the Rice campus at a hybrid event. Most attendees tuned in via webcast while university president, David Leebron, and Provost Reggie DesRoches hosted U.S. Army Futures Command Lt. Gen. Thomas Todd III and U.S. Rep. Dan Crenshaw, R-Texas.

"The accelerator is the first-of-its-kind, collaborative research facility designed to deploy and develop new technologies for economic and national security," DesRoches says at the event. "The facility includes space for visiting Army Research Lab and (Department of Defense) scientists. We see this as a new model for truly collaborative research that brings together research teams from across the country and across agencies to work on mission-critical technologies."

"We are the only university in the world with a deployed software-defined network already in place," DesRoches continues. "The materials we will discover here with our ARL partners will be rapidly prototyped into devices and deployed."

Walter Jones, executive director of RUNSRA, is a the former executive director of the Office of Naval Research and former director of plans and programs at the Air Force Research Laboratory and joined Rice in June. The goal of the lab and the program is to research technologies to advance the Army's modernization.

"The accelerating pace of technology will continue to change our world," says Todd. "It will require us to re-examine how we compete and, if required, how we win on the future battlefield. And it will require us to develop new technologies that let us compete and win by expanding what is possible, which starts at a place like Rice University.

"I know that tremendous benefit will come from this research accelerator," Todd continues. "And truly, it's meant to be what it says, an accelerator of technologies into the hands of soldiers."

Watch below to view the press conference and ribnbon cutting.

The Rice University National Security Research Acceleratorwww.youtube.com

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Intel Corp. and Rice University sign research access agreement

innovation access

Rice University’s Office of Technology Transfer has signed a subscription agreement with California-based Intel Corp., giving the global company access to Rice’s research portfolio and the opportunity to license select patented innovations.

“By partnering with Intel, we are creating opportunities for our research to make a tangible impact in the technology sector,” Patricia Stepp, assistant vice president for technology transfer, said in a news release.

Intel will pay Rice an annual subscription fee to secure the option to evaluate specified Rice-patented technologies, according to the agreement. If Intel chooses to exercise its option rights, it can obtain a license for each selected technology at a fee.

Rice has been a hub for innovation and technology with initiatives like the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion.

The university has also inked partnerships with other tech giants in recent months. Rice's OpenStax, a provider of affordable instructional technologies and one of the world’s largest publishers of open educational resources, partnered with Microsoft this summer. Google Public Sector has also teamed up with Rice to launch the Rice AI Venture Accelerator, or RAVA.

“This agreement exemplifies Rice University’s dedication to fostering innovation and accelerating the commercialization of groundbreaking research,” Stepp added in the news release.

Houston team develops low-cost device to treat infants with life-threatening birth defect

infant innovation

A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies has developed a cost-effective treatment for infants born with gastroschisis, a congenital condition in which intestines and other organs are developed outside of the body.

The condition can be life-threatening in economically disadvantaged regions without access to equipment.

The Rice-developed device, known as SimpleSilo, is “simple, low-cost and locally manufacturable,” according to the university. It consists of a saline bag, oxygen tubing and a commercially available heat sealer, while mimicking the function of commercial silo bags, which are used in high-income countries to protect exposed organs and gently return them into the abdominal cavity gradually.

Generally, a single-use bag can cost between $200 and $300. The alternatives that exist lack structure and require surgical sewing. This is where the SimpleSilo comes in.

“We focused on keeping the design as simple and functional as possible, while still being affordable,” Vanshika Jhonsa said in a news release. “Our hope is that health care providers around the world can adapt the SimpleSilo to their local supplies and specific needs.”

The study was published in the Journal of Pediatric Surgery, and Jhonsa, its first author, also won the 2023 American Pediatric Surgical Association Innovation Award for the project. She is a recent Rice alumna and is currently a medical student at UTHealth Houston.

Bindi Naik-Mathuria, a pediatric surgeon at UTMB Health, served as the corresponding author of the study. Rice undergraduates Shreya Jindal and Shriya Shah, along with Mary Seifu Tirfie, a current Rice360 Global Health Fellow, also worked on the project.

In laboratory tests, the device demonstrated a fluid leakage rate of just 0.02 milliliters per hour, which is comparable to commercial silo bags, and it withstood repeated disinfection while maintaining its structure. In a simulated in vitro test using cow intestines and a mock abdominal wall, SimpleSilo achieved a 50 percent reduction of the intestines into the simulated cavity over three days, also matching the performance of commercial silo bags. The team plans to conduct a formal clinical trial in East Africa.

“Gastroschisis has one of the biggest survival gaps from high-resource settings to low-resource settings, but it doesn’t have to be this way,” Meaghan Bond, lecturer and senior design engineer at Rice360, added in the news release. “We believe the SimpleSilo can help close the survival gap by making treatment accessible and affordable, even in resource-limited settings.”